Immunodominant CD8 T cell response to Epstein-Barr virus

Biomedicine and Pharmacotherapy

Volumn 55, Issue 7, 2001, Pages 373-380

  Houssaint, E ^a   Saulquin, X ^a   Scotet, E ^a   Bonneville, M ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

CD8 T cell; Epstein Barr virus; Immunodominance

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; IMMEDIATE EARLY PROTEIN; VIRUS PROTEIN;

ANTIGEN SPECIFICITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HERPES VIRUS; HUMAN; IMMUNE RESPONSE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS DETECTION; VIRUS INFECTION;

EID: 0034802921     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(01)00082-8     Document Type: Article

References (41)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus
3. EBV persistence in memory B cells in vivo
4. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
5. + T cell response: Lessons from the EBV nuclear antigen EBNA1
6. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus
7. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
8. Vital involvement of a natural killer cell activation receptor in resistance to viral infection
9. + T cells in acute infectious mononucleosis
10. + T cells during the primary immune response to Epstein-Barr virus in vivo
11. Dominant cytotoxic T lymphocyte response to the immediate early transactivator protein BZLF1, in persistent type A or B Epstein-Barr virus infection
12. A highly sensitive cell line, Wehi 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
13. Multiple HLA-A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4
14. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte response
15. Localisation of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development
16. Immune regulation in Epstein-Barr virus-associated diseases
17. EBV-infected B cells in infectious mononucleosis: Viral strategies for spreading in the B cell compartment and establishing latency
18. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
19. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
20. Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype
21. Cytotoxic T cell clones discriminate between A- and B-type Epstein-Barr transformants
22. +T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
23. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies
24. + T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation
25. Epstein-Barr virus
26. Human cytotoxic T lymphocyte responses to Epstein-Barr infection
27. + T-helper and a T-killer cell
28. A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening
29. Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context. Evidence for a TAP-independent processing
30. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis
31. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: Towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes
32. Epitope focusing in the primary cytotoxic T-cell response to Epstein-Barr virus and its relationship to T cell memory
33. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response
34. + T cells specific for EBV in healthy virus carriers
35. + T cells that are specific for certain viral epitopes
36. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
37. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human lymphocytes
38. Epstein-Barr virus-specific cytotoxic T cell clones restricted through a single HLA antigen
39. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals
40. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
41. Viral immune evasion due to persistence of activated T cells without effector function